Akums' Tablet-in-Capsule Technology Enhances Drug Delivery| or| "The Future of CDMO: Advances in Tablet-in-Capsule Techn

Posted by Akums Drugs & Pharmaceuticals Ltd on June 10th, 2023

Tablet in Capsule Technology

Though technology has taken a big leap and time has completely changed yet tablet in a capsule is considered the most popular way of acceptance by customers. The tablet in the pill is a multifunctional and multiple-unit system, which comprises adaptable mini-tablets in a hard gelatin capsule. It can be industrialized by formulating Quick-release miniature -Tablets, Sustained-release Miniature Tablets, Pulsatile Mini-Tablets, and Delayed-onset Sustained-release Mini-Tablets, each with numerous interval times of release and summarizing in a capsule.

CDMOs with the newest technology

CDMOs (Contract Development and Manufacturing Organizations) are companies that provide comprehensive services to pharmaceutical and biotech companies, ranging from the development of new drugs to their manufacture and distribution. One of the key areas for CDMOs is the production of tablets and capsules, which are the most common forms of medication.

Advances in tablet-in-capsule technology have significant implications for CDMOs. Specifically, this technology enables pharmaceutical companies to combine multiple drugs with different release profiles in a single dosage form. This approach allows for improved medication adherence and better patient outcomes.

The basic principle behind tablet-in-capsule technology is relatively simple. A tablet is placed inside a specially designed capsule shell, which is then closed. This creates a single dosage form that has the convenience of a capsule with the active ingredients of a tablet. The tablet can also be designed to release over a specific period to provide sustained release.

This technology has significant benefits for both pharmaceutical companies and patients. For pharmaceutical companies, it provides a more efficient process for drug development and manufacturing, reducing the costs associated with producing multiple dosage forms. For patients, tablet-in-capsule technology enables easier adherence to complex medication regimens and improves patient outcomes.

In conclusion, advances in tablet-in-capsule technology have significant implications for CDMOs and the pharmaceutical industry as a whole. By improving medication adherence and patient outcomes, this technology has the potential to revolutionize the way we think about medication delivery.

Akums Drugs and Pharmaceuticals Ltd.

Akums Drugs and Pharmaceuticals Ltd. is a Who-GMP certified one of the renowned contract developing and manufacturing organizations that are known to stay ahead in the areas of technology and advancement. Time when companies are adopting this tablet in capsule technology, Akums is well versed in this adaptive technology. Akums provide comprehensive services to its associates which comprise advancement, perfection, and flawlessness. Tablet in the capsule is one such technique that has enhanced the drug delivery system of Akums by being proficient in the same and the industry.